George Bardenheier is currently the Associate Director of Strategy and Operations for the US Rare Disease Franchise at Biogen, a position held since 2025. They have previously contributed as a Senior Consultant at Trinity Life Sciences and as an MBA Intern at Bristol Myers Squibb. Additionally, George has experience as an MBA Consultant at OpenDNA Ltd and has held multiple consulting roles at Deloitte. They earned a Bachelor of Arts in International Affairs from The George Washington University and completed their MBA at the University of Michigan's Stephen M. Ross School of Business in 2022.
Location
Boston, United States